期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 135, 期 21, 页码 8071-8077出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja4033956
关键词
-
资金
- EPSRC
- GlaxoSmithKline
A strategy for the generation of enantiomerically pure alpha-functionalized chiral Grignard reagents is presented. The approach involves the synthesis of alpha-alkoxy and alpha-amino sulfoxides in >= 99:1 dr and >= 99:1 er via asymmetric deprotonation (s-BuLi/chiral diamine) and trapping with Andersen's sulfinate (menthol derived). Subsequent sulfoxide -> Mg exchange (room temperature, 1 mm) and electrophilic trapping delivers a range of enantiomerically pure alpha-alkoxy and alpha-amino substituted products Using this approach, either enantiomer of products can be accessed in 99:1 er from asymmetric deprotonation protocols without the use of (-)-sparteine as the chiral ligand. Two additional discoveries are noteworthy: (i) for the deprotonation and trapping with Andersen's sulfinate, there is a lack of stereospecificity at sulfur due to attack of a lithiated intermediate onto the alpha-alkoxy and alpha-amino sulfoxides as they form, and (ii) the alpha-alkoxy-substituted Grignard reagent is configurationally stable at room temperature for 30 min.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据